Back to Cullen Capital Management, LLC Cullen Capital Management, LLC

BMYBMY
Showing 8 of 28 quarters

Position history for Cullen Capital Management, LLCCullen Capital Management, LLC's holdings in Bristol-Myers Squibb Company

Yes. Cullen Capital Management holds 1,132,367 shares of BMY (Bristol-Myers Squibb), worth $65.2M, as of its Q2 2026 13F filing. It increased the position by 12,698 shares (+1.1%) from Q1 2026. Cullen Capital Management has held BMY since Q3 2019, across 28 quarterly 13F filings. BMY is 0.6% of Cullen Capital Management's reported 13F portfolio.

Current Value

$65.2M

Current Shares

1.1M

Total Value Change

-$2.6M

Total Shares Change

-178,636

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+1.1%
$65.2M0.6%$56.98
42
2026-Q1
Decreased
1.1M
-4.8%
$67.9M0.7%$59.36
0
2025-Q4
Decreased
1.2M
-12.2%
$63.5M0.7%$52.18
0
2025-Q3
Increased
1.3M
+6.3%
$60.5M0.7%$43.03
44
2025-Q2
Increased
1.3M
+12.7%
$58.4M0.7%$43.59
47
2025-Q1
Decreased
1.1M
-4.1%
$68.2M0.8%$56.82
0
2024-Q4
Decreased
1.2M
-11.1%
$66M0.8%$52.12
0
2024-Q3
Decreased
1.3M
-11.8%
$67.8M0.7%$47.15
0

Other major holders of BMY: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used